Related references
Note: Only part of the references are listed.A prostacyclin analog prevents the regression of renal microvascular network by inhibiting mitochondria-dependent apoptosis in the kidney of rat progressive glomerulonephritis
Yasufumi Goto et al.
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2014)
A multinational phase IIb/III trial of beraprost sodium, an orally active prostacyclin analogue, in patients with primary glomerular disease or nephrosclerosis (CASSIOPEIR trial), rationale and study design
Hidetomo Nakamoto et al.
BMC NEPHROLOGY (2014)
Beraprost sodium improves survival rates in anti-glomerular basement membrane glomerulonephritis and 5/6 nephrectomized chronic kidney disease rats
Shinichi Yamaguchi et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2013)
The Mutation, a Key Determinant of Phenotype in ADPKD
Peter C. Harris et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2013)
Combined Angiotensin Inhibition for the Treatment of Diabetic Nephropathy
Linda F. Fried et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Cardiorenal End Points in a Trial of Aliskiren for Type 2 Diabetes
Hans-Henrik Parving et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Effects of olmesartan on renal and cardiovascular outcomes in type 2 diabetes with overt nephropathy: a multicentre, randomised, placebo-controlled study
E. Imai et al.
DIABETOLOGIA (2011)
Noninvasive Evaluation of Kidney Hypoxia and Fibrosis Using Magnetic Resonance Imaging
Tsutomu Inoue et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)
Current Status of Dialysis Therapy in Korea
Dong Chan Jin
KOREAN JOURNAL OF INTERNAL MEDICINE (2011)
Attenuation of immune complex nephritis in NZB/WF1 mice by a prostacyclin analogue
Y. UTSUNOMIYA et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2010)
The Prostacyclin Analog Beraprost Sodium Ameliorates Characteristics of Metabolic Syndrome in Obese Zucker (Fatty) Rats
Nahoko Sato et al.
DIABETES (2010)
Epidemiology, impact and preventive care of chronic kidney disease in Taiwan
Shang-Jyh Hwang et al.
NEPHROLOGY (2010)
Revised Equations for Estimated GFR From Serum Creatinine in Japan
Seiichi Matsuo et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2009)
Amelioration of Diabetic Nephropathy in OLETF Rats by Prostaglandin I-2 Analog, Beraprost Sodium
Maho Watanabe et al.
AMERICAN JOURNAL OF NEPHROLOGY (2009)
Iloprost Prevents Contrast-Induced Nephropathy in Patients With Renal Dysfunction Undergoing Coronary Angiography or Intervention
Konstantinos Spargias et al.
CIRCULATION (2009)
Telmisartan, ramipril, or both in patients at high risk for vascular events
Salim Yusuf et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Epidemiology, major outcomes, risk factors, prevention and management of chronic kidney disease in China
Yuansheng Xie et al.
AMERICAN JOURNAL OF NEPHROLOGY (2008)
Protective effect of cyclic AMP against cisplatin-induced nephrotoxicity
Kazuto Mishima et al.
FREE RADICAL BIOLOGY AND MEDICINE (2006)
Chronic hypoxia and tubulointerstitial injury: A final common pathway to end-stage renal failure
Masaomi Nangaku
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Clinical and experimental evidence for prevention of acute renal failure induced by radiographic contrast media
Y Itoh et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2005)
Effect of long-term administration of prostaglandin I2 in incipient diabetic nephropathy
A Owada et al.
NEPHRON (2002)
A role for uric acid in the progression of renal disease
DH Kang et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2002)
Prostacyclin-deficient mice develop ischemic renal disorders, including nephrosclerosis and renal infarction
C Yokoyama et al.
CIRCULATION (2002)
Amelioration by beraprost sodium, a prostacyclin analogue, of established renal dysfunction in rat glomerulonephritis model
M Yamada et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2002)
PGI2 analogue mitigates the progression rate of renal dysfunction improving renal blood flow without glomerular hyperfiltration in patients with chronic renal insufficiency
T Fujita et al.
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2001)
Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy
BM Brenner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Comparative effects of beraprost, a stable analogue of prostacyclin, with PGE1, nitroglycerin and nifedipine on canine model of vasoconstrictive pulmonary hypertension
M Tamura et al.
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2001)
Is there a common mechanism for the progression of different types of renal diseases other than proteinuria? Towards the unifying theme of chronic hypoxia
LG Fine et al.
KIDNEY INTERNATIONAL (2000)